Three Arch Partners Mergers & Acquisitions

Three Arch Partners M&A Summary

The Firm’s most common exit type is trade sale (67%). Three Arch Partners’ largest (disclosed) exit occurred in 2009 when it sold Visiogen for $400M.

Sign-up to view Three Arch Partners’ full profile and discover more large investors just like it.

M&A Summary

  • M&A Total Activity51
    • M&A Buy Activity27
    • M&A Sell Activity24
  • M&A Buy/Sell Connections31

Three Arch Partners

19 South B Street, Suite 14,
San Mateo, California 94401
United States
(650) 529-8000
www.threearchpartners.com
info@threearchpartners.com

All (51) Buy (27) Sell (24)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2017-03-17 Threshold Pharmaceuticals, Inc. · Life Science
South San Francisco, California · www.thresholdpharm.com

Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of cancer.

Advisors: Cooley , Ladenburg Thalmann & Co.
- Merger

Molecular Templates
Advisors: Mintz Levin Cohn Ferris Glovsky and Popeo , Pillsbury Winthrop Shaw Pittman

Alta Partners PE

Three Arch Partners PE


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.